[Domestic first AI-assisted innovative drug approved for marketing] September 6th, according to news from Westlake University, the innovative drug - isestrevir hydrochloride tablets (trade name: Elpresvir) jointly developed by Westlake University, Westlake Laboratory, and Westlake Pharmaceuticals has recently been officially approved by the National Medical Products Administration with conditional approval for marketing. This is the first Class 1 innovative drug completely independently developed by Westlake University and is used for the treatment of mild and medium-sized novel coronavirus infections in adults. Category 1 innovative drugs are the highest level in China's drug registration classification, representing source innovation from 0 to 1. Its core lies in having a new chemical structure, a new mechanism of action, and having clear clinical value.